Have to say this rings pretty true. I’m not a speccy investor generally however PAB caught my eye around 0.007 and I figured it was worth a flutter. I’d say this is an extremely risky investment, the potential to make big gains is there but there’s also big potential to lose the lot, I wrote off the money i invested here off the bat as a precaution.
hoping to see a successful GMP run here and kicking off trials. I’m not a big fan of the way this company communicates to be honest, but always have to remember in biotech they always say clinical trials are only x amount of days/weeks away before the next delay its just par for the course in this industry unfortunately. However things could start to turn around if a gmp is successful with money flowing back into the sector, it’s going to be a long game though, ultimately need runs on the board before people start daydreaming of deals it’s a long way off if it’s to happen. All imo, cheers
- Forums
- ASX - By Stock
- PAB
- Ann: Presentation to highlight broader potential of Deoxymabs
Ann: Presentation to highlight broader potential of Deoxymabs, page-70
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $3.172K | 453.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 3529290 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 1082143 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 154965 | 0.008 |
17 | 3458290 | 0.007 |
12 | 2704182 | 0.006 |
10 | 3960042 | 0.005 |
5 | 4174000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 154966 | 1 |
0.008 | 927177 | 7 |
0.009 | 1358703 | 2 |
0.010 | 306000 | 3 |
0.011 | 1780000 | 4 |
Last trade - 10.50am 18/06/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online